The Board of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. proposed a final dividend for the year ended 31 December 2021, before tax, amounted to RMB 0.56 per share, which is subject to the approval of the Shareholders at the forthcoming annual general meeting (the AGM'). Subject to the approval of the Shareholders at the AGM, the 2021 Final Dividend is expected to be paid to the eligible Shareholders by no later than 31 August 2022. Record date is March 22, 2022.